Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...

There’s no single test that can diagnose multiple ... active lesions often show inflammatory demyelination, while old lesions may show scarring that is often described as “sclerosis.” ...

Multiple sclerosis (MS) is one of the most widespread ... and neurons in the brain and spinal cord. Together these make up the central nervous system. Researchers speculate that a combination ...

Having presented new data at last year’s European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS ... around nerves in the brain and spinal cord, damaging the myelin and ...

Since announcing her multiple sclerosis diagnosis in 2018, Selma Blair has been an outspoken advocate for people with MS. The autoimmune condition can be difficult to diagnose-in fact, nearly one in ...

Bradford B. Worrall, MD, a University of Virginia professor of neurology and public health, says many stroke survivors develop spasticity.

Experts in Australia and New Zealand have published the first consensus guidelines for the care of adults with MS in those ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

If you've been diagnosed with multiple sclerosis (MS), it's time to start exploring ... which means they can't circulate and create brain and spinal cord lesions. They are the only FDA-approved ...

Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block ... A doctor will monitor to see if any new lesions develop and in which are areas of the brain ...